CPT code 67031 is a medical billing code for laser surgery targeting eye strands, specifically vitreous strands.
CPT code 67031 is designated for laser surgery involving the eye, specifically targeting strands in the vitreous of the eye. This procedure is typically used to treat conditions where these strands cause visual impairment or other complications.
For CPT code 67031, which involves laser surgery on eye strands, several modifiers may be applicable depending on the specific circumstances of the surgery and billing requirements. Here’s an ordered list of potential modifiers and the reasons for their use:
1. -LT (Left side): Used to indicate that the procedure was performed on the left eye.
2. -RT (Right side): Used to indicate that the procedure was performed on the right eye.
3. -50 (Bilateral procedure): Applied when the procedure is performed on both eyes during the same operative session.
4. -26 (Professional component): This modifier is used when only the professional component of the procedure (i.e., the work performed by the healthcare provider) is being billed, not the facility or equipment usage.
5. -TC (Technical component): Indicates that only the technical component (i.e., equipment or facility use) is being billed, not the professional services.
6. -22 (Increased procedural services): Used when the work required to perform the surgery is substantially greater than typically required, which should be documented thoroughly.
7. -59 (Distinct procedural service): Indicates that the procedure is not typically bundled with other services, but is distinct and separate when performed on the same day.
8. -78 (Return to the operating room for a related procedure during the postoperative period): Used if the patient must return to the operating room for a procedure related to the original surgery during the recovery period.
9. -79 (Unrelated procedure or service by the same physician during the postoperative period): This modifier is used if a new procedure (unrelated to the initial surgery) is performed while the patient is still in the postoperative period for the initial surgery.
Each modifier has specific billing implications and requirements for documentation, so it's crucial to apply them correctly to ensure proper reimbursement and compliance with payer policies.
CPT code 67031, which refers to laser surgery for eye strands (specifically, lysis of vitreous strands via laser), is typically reimbursable by Medicare. However, the actual reimbursement can vary based on the Medicare Administrative Contractor (MAC) that governs the jurisdiction in which the procedure is performed.
The reimbursement amount for CPT code 67031 can also differ depending on several factors, including the setting in which the procedure is performed (e.g., outpatient hospital, ambulatory surgery center, or physician's office) and the geographic location. To determine the exact reimbursement amount, it is advisable to consult the fee schedule provided by the local MAC or use the Medicare Physician Fee Schedule Look-Up Tool available on the CMS (Centers for Medicare & Medicaid Services) website.
It's important for healthcare providers to verify coverage and obtain any necessary pre-authorizations from Medicare before performing the procedure, as failure to comply with Medicare's policies could result in denial of reimbursement. Additionally, documentation should clearly support the medical necessity of the procedure to ensure compliance and facilitate appropriate reimbursement.
Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately detecting underpayments. RevFind is adept at reading your contracts and identifying discrepancies down to specific CPT codes, such as 67031 for laser surgery eye strands, ensuring that each service rendered is fully compensated according to your payer agreements. Schedule a demo today to see how RevFind can help secure the payments you are entitled to from individual payers.
Get paid in full by bringing clarity to your revenue cycle
Subscribe to the
Healthcare Clarified newsletter
Get the latest insights on RCM and healthcare policy in your inbox
